Welcome to our dedicated page for Selectis Health news (Ticker: GBCS), a resource for investors and traders seeking the latest updates and insights on Selectis Health stock.
Selectis Health Inc. operates as a public healthcare company focused on healthcare facilities that provide living services, speech, occupational and physical therapies, social services, rehabilitation and related healthcare services. The company has described its facility footprint across Arkansas, Georgia, Ohio and Oklahoma, with an emphasis on care settings serving aging populations.
Recurring developments for GBCS include skilled nursing facility portfolio changes, completed asset sales, material agreements, capital-structure updates, shareholder voting matters and operating and financial results. Company announcements also cover governance changes, including board and executive appointments, as well as healthcare regulatory disclosure topics tied to its facility operations.
Summary not available.
Selectis Health, Inc. (OTC: GBCS) reported a 31% increase in Q3 2022 revenue, reaching $9.6 million, up from $7.3 million year-over-year. However, the company faced a net loss of $1.0 million, or $(0.33) per share, compared to a net loss of $0.06 million, or $(0.02) per share in the prior year. Selectis continues to enhance operational efficiencies and optimize costs through group purchasing agreements projected to save 4% annually. Recent strategic hires and training programs aim to improve patient census and profitability as they adapt to ongoing healthcare sector changes.
Selectis Health is set to present at the Rocky Mountain Microcap Conference X on November 10, 2022, at TopGolf, Centennial, Colorado. The presentation will occur at 1:52 p.m. Mountain Time. Selectis Health operates healthcare facilities across several states, including Arkansas, Georgia, Ohio, and Oklahoma, focusing on a wide variety of healthcare services. The company aims to enhance its presence in the Southcentral and Southeastern U.S. to better serve the aging population.
Selectis Health announced the appointment of Andrew Sink as an independent director, effective October 17, 2022, filling the vacancy left by Clifford Neuman's resignation as director and secretary. Sink, with over 30 years of real estate experience, is expected to provide valuable insights as the company pursues its business transformation and compliance for a major national exchange listing. His extensive background includes managing private equity funds totaling over $100 million and involvement in transactions exceeding $700 million. CEO Lance Baller emphasizes Sink's crucial role in advancing strategic progress.
Greenwood Village, CO, Oct. 17, 2022 – Selectis Health (OTC: GBCS) will present at the 15th Annual LD Micro Main Event, taking place at the Luxe Sunset Bel Air Hotel in Los Angeles from October 25-27, 2022. Management is set to present on October 25 at 12:30 p.m. PT. The event features over 200 companies and will include live webcasts of presentations. For further inquiries or to arrange meetings with management, contact the investor relations team via email. Selectis provides healthcare services across multiple states, focusing on community relationships and quality care.
Selectis Health reports strong financial results for Q2 2022, with revenue rising 91% year-over-year to $11.5 million and net income reaching $1.0 million.
Recent compliance with SEC reporting obligations follows challenges in auditing previous financial statements. The company has optimized operations by hiring additional financial and healthcare staff, driving improvements in patient occupancy rates across facilities.
Looking ahead, Selectis aims to continue enhancing profitability and operational efficiency while preparing for a potential listing on a national exchange.
Selectis Health, Inc. (OTC: GBCS) reported a revenue increase of over 75% year-over-year for Q1 2022. The company has improved patient census across its facilities while facing delays in financial audits. Interim CFO Christine Lucus has been appointed, and David Furstenberg joins the Board of Directors to enhance corporate governance. Selectis has secured direct billing approvals for all its facilities and aims to eliminate third-party staffing needs by year-end 2022. The company is focused on operational upgrades and maximizing profitability.
Selectis Health, Inc. (OTC: GBCS) has announced a postponement of its scheduled conference call on April 26, 2022, due to additional time needed to finalize the audit of its 2021 financial statements. The company is committed to reporting its fourth quarter and full year 2021 financial results as soon as possible. An update on the timing for the rescheduled conference call will be provided within the next few business days. Selectis operates healthcare facilities across several states, focusing on improving the quality of care for residents.
Selectis Health (OTC: GBCS) will host a conference call on April 26, 2022, at 4:30 p.m. ET to discuss its financial results for Q4 and FY 2021. A press release detailing the results will precede the call. Interested parties can join by dialing 1-877-704-4453 (toll-free) or 1-201-389-0920 (international) and using Conference ID: 13727317. A replay will be available after 7:30 p.m. ET on the same day until May 10, 2022. Selectis Health provides a variety of healthcare services across several states, focusing on strategic community partnerships.
Selectis Health has engaged Gateway Group to enhance its investor relations initiatives. This partnership aims to improve corporate messaging, develop outreach programs, and facilitate connections with institutional investors and analysts. CEO Lance Baller emphasized the strategic timing following operational progress in 2021 and a completed rebranding. The collaboration aims to promote Selectis' growth story to a broader audience and enhance market awareness as it seeks to deepen its presence in the Southcentral and Southeastern U.S. healthcare markets.